Select Committee on Intergovernmental Organisations Minutes of Evidence


Annex

1.  Q. 1142  Whether the UK Government plays a part in programmes to strengthen the infrastructure for animal health care and to ensure that within those countries the strategies are coordinated.

  The UK strengthens animal health care in developing countries through applied research and the promotion of policies and institutions that support poor livestock keepers. For example, the European Union's animal health infrastructure and capacity building programmes are supported via UK contributions to the European Commission including the recent €72 million, 32 country, Programme for the Pan African Control of Epizootics.

  DFID provides direct support to the Pro-Poor Livestock Policy Initiative within the UN's Food and Agriculture Organisation (FAO). This programme was mentioned in the independent external evaluation of FAO as influential and an example of best practice. In 2007, DFID established a public-private partnership, the Global Alliance for Livestock Vaccines (GALV) to develop, commercialise and deliver new vaccine technologies for diseases that affect the poorest livestock keepers.

  The Alliance will soon receive $24 million of co-funding from the Bill and Melinda Gates Foundation. The threat of highly pathogenic avian influenza is being addressed through national level control and surveillance projects in selected countries such as Kenya and Ethiopia. DFID also supports research on the best policy options for developing countries faced with avian flu epizootics. In 2007 DFID seconded an expert for three years to the World Organisation for Animal Health (OIE) to strengthen developing county laboratories by twinning them with World Reference Laboratories.

2.  Q. 1159  What the UK is doing to ensure that programmes to treat TB and HIV/AIDS are integrated.

  The Department for International Development (DFID) is working with the global health partnerships and international financial institutions to improve programme integration in developing countries. Two examples from the bilateral programme:

  In Zambia DFID is implementing two joint HIV/Tuberculosis projects under the auspices of the Zambia AIDS Related Tuberculosis (ZAMBART) Project a collaborative effort between the University of Zambia, School of Medicine and the London School of Hygiene and Tropical Medicine. Funding initially came from DFID-UK only and now includes the Bill and Melinda Gates Foundation, EC, The Beit Trust and WHO. Zambia has benefited from recommendations for improving HIV care that includes the policy to test all HIV positive patients for TB and vice versa.

  £100 million UK funding to the Malawi health Sector Wide Approach (SWAp) supports the implementation of the national TB protocol, and guidelines that prioritise the integration of HIV and TB services. Until 2005, the National TB Programme operated largely independently from the main health system, but since then, TB funding from DFID and the Global Fund has been pooled as funding for delivery of the overall Essential Health Package. The TB and HIV units work together to cross-refer patients for testing and coordinate treatment regimens, although recent findings show that due to limited access to district hospitals there is a low uptake of Anti Retroviral Treatment (ART) by many HIV+ patients referred on from TB treatment. The Ministry of Health and National AIDS commission continue to work hard to increase the number of facilities able to offer ART. By December 2007, 146,000 people had commenced ART in Malawi.

3.  Q. 1162-1164  How the UK Government applies its criteria to decide whether to reduce or suspend aid to a recipient country government or to deliver it in a different way (by-passing the national government) to ensure the aid reaches people who need it. In particular, how did the UK provide aid in response to the humanitarian crisis in Uganda in 2005. Did the UK Government continue to provide aid through the Government in Kampala even though it was clear that this Government was not interested in ensuring that the money got through to the people in Northern Uganda who needed it?

  DFID only uses Poverty Reducing Budget Support (PRBS) with partner governments committed to poverty reduction, improving public financial management, good governance and human rights and when PRBS will achieve greater impact than other forms of aid.

  DFID is alert to the risk of corruption or misuse. DFID protects its funds in three ways:

    —  Assessing risks carefully before we give budget support.

    —  Addressing underlying problems—support to strengthen public financial management systems.

    —  If necessary, using short-term safeguards eg extra audits.

  If something happens to bring into significant doubt the partner government's commitment to public financial management reform and accountability, DFID will then reassess if budget support remains appropriate. If necessary, we reduce or suspend aid, or deliver it in a different way.

  In December 2005 DFID reallocated £15 million of the bilateral aid programme to help the UN provide humanitarian relief in northern Uganda (bringing our total expenditure on the humanitarian effort in the North to £20 million in 2005-06). At the same time we decided to reduce our planned disbursement through the Government by £15 million.

  Since early 2006 the government system of allocating resources has resulted in a significant increase in financing to the North. It is estimated that regular central government transfers to northern districts affected by the conflict with the Lord's Resistance Army increased from about US$ 97 million in 2005-06 to about US$ 114 million in 2006-07.

4.  Q. 1165-1167  A list of the ten other donors that the UK is working with, through MOPAN, to develop a common approach to multi-lateral effectiveness.

  The 10 donors are Austria, Canada, Denmark, Finland, France, Ireland, The Netherlands, Norway, Sweden, Switzerland. The Republic of Korea, Spain and Australia have recently applied for membership and have been invited to join as observers.

5.  Q. 1174  The seven countries where the UK is funding/piloting the Medicines Transparency Alliance.

Ghana
Uganda
Zambia
Jordan
Kyrgyzstan
Peru
Philippines.





 
previous page contents

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2008